Characteristics of activated monocyte phenotype support R5-tropic human immunodeficiency virus

Immunology and Immunogenetics Insights

Volumn 1, Issue 1, 2009, Pages 15-20

  Munsaka, Sody M ^a   Agsalda, Melissa ^a   Troelstrup, David ^a   Hu, Ningjie ^a   Yu, Qigui ^a   Shiramizu, Bruce ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Activation; Dementia; Human immunodeficiency virus; Monocytes

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79251605975     PISSN: None     EISSN: 11786345     Source Type: Journal    
DOI: 10.4137/iii.s2011     Document Type: Article

References (16)

1. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE. 2008;3:e2516.
2. Kusdra L, McGuire D, Pulliam L. Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. Aids. 2002;16:31-38.
3. Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci. 2002;25:537-562.
4. Gorry PR, Taylor J, Holm GH, Mehle A, Morgan T, Cayabyab M, et al. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol. 2002;76:6277-6292.
5. Kaufmann A, Salentin R, Gemsa D, Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol. 2001;69:248-252.
6. Ruitenberg JJ, Mulder CB, Maino VC, Landay AL, Ghanekar SA. VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples. BMC Immunol. 2006;7:11.
7. Benveniste O, Dereuddre-Bosquet N, Clayette P, Leport C, Vilde JL, Dormont D. High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome. Clin Exp Immunol. 2000;121:320-323.
8. Muller F, Aukrust P, Nordoy I, Froland SS. Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion. Blood. 1998;92:3721-3729.
9. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006;22: 757-762.
10. Adib-Conquy M, Petit AF, Marie C, Fitting C, Cavaillon JM. Paradoxical priming effects of IL-10 on cytokine production. Int Immunol. 1999;11:689-698.
11. Houle M, Thivierge M, Le Gouill C, Stankova J, Rola-Pleszczynski M. IL-10 up-regulates CCR5 gene expression in human monocytes. Inflammation. 1999;23:241-251.
12. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584-592.
13. Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol. 1999;21: 565-582.
14. Franchin G, Zybarth G, Dai WW, Dubrovsky L, Reiling N, Schmidtmayerova H, Bukrinsky M, Sherry B. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J Immunol. 2000;164:2592-2601.
15. Seta N, Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J Med. 2007;56:41-47.
16. Caldwell DJ, Evans JD. Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection. Expert Opin Pharmacother. 2008;9: 3231-3242.